Abstract
Gliptins are high quality antidiabetics. These properties are important for use in therapy.
1. simplicity of administration,
2. practical absence of side effects,
3. minimal risk of hypoglycemia,
4. sufficient effectiveness,
5. cardiovascular safety. Gliptins are suitable for initial treatment in patients with a recent diagnosis and sufficiently preserved insulin secretion without manifestation of atherosclerotic complications, for seniors, diabetics with a short life expectancy. According to the relevant summary of product characteristics for each product, they can be used in virtually any combination with other antidiabetics.